Zhou Liqing, Xu Ziran, Ren Xiaoqiang, Chen Kaixuan, Xin Shiyong
Cell Physiol Biochem. 2016;38(5):1785-95. doi: 10.1159/000443117. Epub 2016 May 9.
BACKGROUND/AIMS: MiR-124 inhibits neoplastic transformation, cell proliferation, and metastasis and downregulates Rho-associated protein kinase (ROCK1) in Colorectal Cancer (CRC). The aim of this study was to further investigate the roles and interactions of ROCK1 and miR-124 and the effects of knockdown of ROCK1and MiR-124 in human Colorectal Cancer (CRC).
Three Colorectal cancer cell lines (HCT116, HT29 and SW620) and one Human Colonic Mucosa Epithelial cell line (NCM460) were studied. The protein expression of ROCK1 was examined by Western-blot and qRT-PCR were performed to examine the expression levels of ROCK1 mRNA and miR-124. Furthermore, We performed transfection of cancer cell line (SW620) with pre-miR-124(mimics), anti-miR-124(inhibitor), ROCK1 siRNA and the control, then observed the affects of ROCK1 protein expression by westen-blot, cell proliferation by EDU (5-ethynyl-2'deoxyuridine assay) and expression levels of ROCK1mRNA by qRT-PCR . A soft agar formation assay, Migration and invasion assays were used to determine the effect of regulation of miR-124 and ROCK1, and survivin on the transformation and invasion capability of colorectal cancer cell.
MiR-124 expression was significantly downregulated in CRC cell lines compare to normal (P < 0.05). In contrast, ROCK1 protein expression was significantly increased in CRC cell lines compared to the normal (P < 0.05), whereas the gene (ROCK1mRNA) expression remained unaltered (P > 0.05). ROCK1 mRNA was unaltered in cells transfected with miR-124 mimic and miR-124 inhibitor, compared to normal controls. There was a significant reduction in ROCK1 protein in cells transfected with miR-124 mimic and a significant increase in cells transfected with miR-124 inhibitor (P < 0.05). Cell proliferation, transformation and invasion of cells transfected with miR-124 inhibitor were significantly increased compared to those in normal controls (P<0.05). However, cell proliferation, transformation and invasion of cells transfected with ROCK1 siRNA were significantly decreased compared to control (P < 0.05).
In conclusion, our results demonstrated that miR-124 not only promoted cancer cell hyperplasia and significantly associated with CRC metastasis and progression, but also downregulated ROCK1 protein expression. More importantly, increased ROCK1 expression or inhibited miR-124 expression may constitute effective new therapeutic strategies for the treatment of renal cancer in the future.
背景/目的:miR-124可抑制结直肠癌(CRC)的肿瘤转化、细胞增殖和转移,并下调Rho相关蛋白激酶(ROCK1)。本研究旨在进一步探究ROCK1与miR-124的作用及相互作用,以及敲低ROCK1和miR-124对人结直肠癌(CRC)的影响。
研究了三种结直肠癌细胞系(HCT116、HT29和SW620)和一种人结肠黏膜上皮细胞系(NCM460)。通过蛋白质免疫印迹法检测ROCK1的蛋白表达,并进行qRT-PCR检测ROCK1 mRNA和miR-124的表达水平。此外,我们用pre-miR-124(模拟物)、抗miR-124(抑制剂)、ROCK1 siRNA和对照转染癌细胞系(SW620),然后通过蛋白质免疫印迹法观察ROCK1蛋白表达的影响,通过EDU(5-乙炔基-2'-脱氧尿苷检测)观察细胞增殖情况,并通过qRT-PCR检测ROCK1 mRNA的表达水平。采用软琼脂形成试验、迁移和侵袭试验来确定miR-124、ROCK1和生存素调控对结直肠癌细胞转化和侵袭能力的影响。
与正常细胞相比,结直肠癌细胞系中miR-124表达显著下调(P<0.05)。相反,与正常细胞相比,结直肠癌细胞系中ROCK1蛋白表达显著增加(P<0.05),而基因(ROCK1 mRNA)表达保持不变(P>0.05)。与正常对照相比,用miR-124模拟物和miR-124抑制剂转染的细胞中ROCK1 mRNA未发生改变。用miR-124模拟物转染的细胞中ROCK1蛋白显著减少,而用miR-124抑制剂转染的细胞中ROCK1蛋白显著增加(P<0.05)。与正常对照相比,用miR-124抑制剂转染的细胞的增殖、转化和侵袭显著增加(P<0.05)。然而,与对照相比,用ROCK1 siRNA转染的细胞的增殖、转化和侵袭显著降低(P<0.05)。
总之,我们的结果表明,miR-124不仅促进癌细胞增生,且与结直肠癌转移和进展显著相关,还下调ROCK1蛋白表达。更重要的是,增加ROCK1表达或抑制miR-124表达可能构成未来治疗肾癌的有效新策略。